fb_script

T1DCRN awards $350K in seed funding grants

Two promising research projects have been targeted to receive contract seed funding grants, and will benefit from $350K in funding from the Type 1 Diabetes Clinical Research Network (T1DCRN), itself an innovative clinical research program led by JDRF Australia and funded by a Special Research Initiative through the Australian Research Council (ARC).

Professor Peter Thorn (left) and Dr Vincent Ho

These two projects will explore new directions in curing and treating T1D and its complications. Read More

Tool could help predict lack of ‘honeymoon phase’ in young people with type 1 diabetes

A new study has developed a prediction tool to help clinicians predict which newly diagnosed children and adolescents are unlikely to experience a period of remission.

The remission phase, also called the honeymoon phase, is the period of time after clinical diagnosis of T1D where the body can make just enough insulin (“endogenous” insulin) to control blood glucose levels either without needing insulin injections or with significantly lower doses.  Read More